221 related articles for article (PubMed ID: 12117612)
41. MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.
Schlenker B; Apfelbeck M; Buchner A; Stief C; Clevert DA
Clin Hemorheol Microcirc; 2018; 70(4):433-440. PubMed ID: 30347605
[TBL] [Abstract][Full Text] [Related]
42. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
Kapustin VV
Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
[TBL] [Abstract][Full Text] [Related]
43. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
[TBL] [Abstract][Full Text] [Related]
44. [Evaluation of methods of detection for prostate neoplasm].
Zhong C; Chen M; Wan B
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):64-6. PubMed ID: 11783074
[TBL] [Abstract][Full Text] [Related]
45. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
[TBL] [Abstract][Full Text] [Related]
46. Re-biopsy of the prostate using a stereotactic transperineal technique.
Moran BJ; Braccioforte MH; Conterato DJ
J Urol; 2006 Oct; 176(4 Pt 1):1376-81; discussion 1381. PubMed ID: 16952636
[TBL] [Abstract][Full Text] [Related]
47. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies.
Kaufmann S; Kruck S; Kramer U; Gatidis S; Stenzl A; Roethke M; Scharpf M; Schilling D
Urol Int; 2015; 94(3):319-25. PubMed ID: 25227711
[TBL] [Abstract][Full Text] [Related]
48. Accuracy of endorectal magnetic resonance/transrectal ultrasound fusion for detection of prostate cancer during brachytherapy.
Bubley GJ; Bloch BN; Vazquez C; Genega E; Holupka E; Rofsky N; Kaplan I
Urology; 2013 Jun; 81(6):1284-9. PubMed ID: 23490527
[TBL] [Abstract][Full Text] [Related]
49. [The value of diffusion-weighted MR imaging combined with transrectal ultrasound for transrectal prostate biopsy].
Wang JY; Shen YJ; Liu XH; Zhang HL; Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhou LP
Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):35-8. PubMed ID: 22490288
[TBL] [Abstract][Full Text] [Related]
50. [Targeted MRI prostate biopsies].
Cohen J; Andre C; Mozer P
Prog Urol; 2016 Nov; 26(14):854-859. PubMed ID: 27751816
[TBL] [Abstract][Full Text] [Related]
51. Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.
Arsov C; Quentin M; Rabenalt R; Antoch G; Albers P; Blondin D
Anticancer Res; 2012 Mar; 32(3):1087-92. PubMed ID: 22399637
[TBL] [Abstract][Full Text] [Related]
52. Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?
Delongchamps NB; Portalez D; Bruguière E; Rouvière O; Malavaud B; Mozer P; Fiard G; Cornud F;
J Urol; 2016 Oct; 196(4):1069-75. PubMed ID: 27079582
[TBL] [Abstract][Full Text] [Related]
53. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.
Lattouf JB; Grubb RL; Lee SJ; Bjurlin MA; Albert P; Singh AK; Ocak I; Choyke P; Coleman JA
BJU Int; 2007 May; 99(5):1041-6. PubMed ID: 17437438
[TBL] [Abstract][Full Text] [Related]
54. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
[TBL] [Abstract][Full Text] [Related]
55. Imaging-guided prostate biopsy: conventional and emerging techniques.
Yacoub JH; Verma S; Moulton JS; Eggener S; Aytekin O
Radiographics; 2012; 32(3):819-37. PubMed ID: 22582361
[TBL] [Abstract][Full Text] [Related]
56. [Recent progress in MRI-ultrasound fusion for guidance of targeted prostate biopsy].
Zhou ZE; Yan WG; Zhou Y; Ji ZG; Li HZ
Zhonghua Wai Ke Za Zhi; 2016 Oct; 54(10):792-796. PubMed ID: 27686645
[TBL] [Abstract][Full Text] [Related]
57. An update on prostate biopsy in the era of magnetic resonance imaging.
Cicione A; De Nunzio C; Manno S; Damiano R; Posti A; Lima E; Tubaro A; Balloni F
Minerva Urol Nefrol; 2018 Jun; 70(3):264-274. PubMed ID: 29595039
[TBL] [Abstract][Full Text] [Related]
58. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
[TBL] [Abstract][Full Text] [Related]
59. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device.
Engelhard K; Hollenbach HP; Kiefer B; Winkel A; Goeb K; Engehausen D
Eur Radiol; 2006 Jun; 16(6):1237-43. PubMed ID: 16447048
[TBL] [Abstract][Full Text] [Related]
60. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
